Noninvasive monitoring of rejection therapy based on intramyocardial electrograms after orthotopic heart transplantation.
Grasser
B
B
Department of Transplantation, Karl-Franzens-Universität Graz, Austria.
Schreier
G
G
Iberer
F
F
Wasler
A
A
Petutschnigg
B
B
Müller
H
H
Prenner
G
G
Hipmair
G
G
Hutten
H
H
Schaldach
M
M
Tscheliessnigg
K H
KH
D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods; D004562:Electrocardiography; D006084:Graft Rejection / Q000188:drug therapy* / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology*; D006352:Heart Ventricles; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D010138:Pacemaker, Artificial; D011239:Prednisolone / Q000627:therapeutic use; D013686:Telemetry
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone